Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
56,047,431
-
Total 13F shares
-
45,333,093
-
Share change
-
-738,006
-
Total reported value
-
$1,144,464,006
-
Put/Call ratio
-
195%
-
Price per share
-
$25.25
-
Number of holders
-
229
-
Value change
-
-$18,622,502
-
Number of buys
-
98
-
Number of sells
-
125
Institutional Holders of SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) as of Q4 2016
As of 31 Dec 2016,
SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) was held by
229 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
45,333,093 shares.
The largest 10 holders included
BlackRock Fund Advisors, VANGUARD GROUP INC, Invesco Ltd., ACADIAN ASSET MANAGEMENT LLC, Bank of New York Mellon Corp, Ranger Investment Management, L.P., STATE STREET CORP, BlackRock Institutional Trust Company, N.A., GLENMEDE TRUST CO NA, and DIMENSIONAL FUND ADVISORS LP.
This page lists
229
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.